日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

PLK1 stabilizes β-catenin to drive colorectal carcinogenesis through NFKB2-mediated transcriptional activation of USP2a and site-specific phosphorylation.

PLK1 通过 NFKB2 介导的 USP2a 转录激活和位点特异性磷酸化,稳定 β-catenin,从而驱动结直肠癌的发生。

Li Yan, Zhao Lili, Deng Jiaqiang, Lu Songmei, Du Jingyu, Chen Chen, Zhao Li, Xu Zhiyun, Wang Wencan, Wang Yundi, Zou Fangdong

USP1 driven mitotic dysregulation and PLK1 stabilization confer Lenvatinib resistance in hepatocellular carcinoma.

USP1 驱动的有丝分裂失调和 PLK1 稳定赋予肝细胞癌 Lenvatinib 耐药性。

Qiang Yuwei, Bian Saiyan, Tong Yun, Chen Weiting, Tang Zhangzhi, Dai Chengchen, Liu Mingyu, Xu Banglong, Jiang Lihan, Ma Kexin, He Xuyang, Li Jinlong, Xiao Mingbing, Zheng Wenjie

Targeting PLK1 Reduces MMP10 to Enhance Radiosensitivity in HPV- Head and Neck Cancer.

靶向 PLK1 可降低 MMP10 以增强 HPV 头颈癌的放射敏感性。

Korns Julianna, Lehn Maria A, Shyamsunder Shreya, Medvedovic Mario, Bryant Stephanie M, Sertorio Mathieu G, Ridinger Maya, Wise-Draper Trisha M, Takiar Vinita

KRAS-Driven Hypertranscription and Metastatic Dissemination in Colorectal Cancer Could be Overcome by Targeting the NMHC IIA/ PLK1 Signaling Axis with a Novel Acridine Derivative.

通过使用新型吖啶衍生物靶向 NMHC IIA/PLK1 信号轴,可以克服 KRAS 驱动的结直肠癌高转录和转移扩散。

Targeting PLK1 potentiates the antitumor efficacy of EGFR-TKIs through inhibiting the JAK1/STAT3 pathway

靶向PLK1可通过抑制JAK1/STAT3通路增强EGFR-TKIs的抗肿瘤疗效。

Li, Cheng; Shi, Shangxuan; Li, Long; Wang, Yafang; Yao, Mingyue; Yu, Chengcheng; Yu, Chuwei; Xie, Chengying

Molecular basis for the activation of Aurora A and Plk1 kinases during mitotic entry.

有丝分裂开始时 Aurora A 和 Plk1 激酶激活的分子基础。

Pillan Anaïs, Ormancey Philippine, Ben Choug Celia, Orlicky Stephen, Tavernier Nicolas, Van Hove Lucie, Ossareh-Nazari Batool, Joly Nicolas, Sicheri Frank, Lorca Thierry, Pintard Lionel

Molecular requirements for PLK1 activation by T-loop phosphorylation.

PLK1通过T环磷酸化激活的分子要求。

Esposito-Verza Arianna, Conti Duccio, Rodrigues Pedroso Paulo D, Oberste-Lehn Lina, Koerner Carolin, Wohlgemuth Sabine, Mansurkhodzhaev Artem, Vetter Ingrid R, Pesenti Marion E, Musacchio Andrea

Copper modulates cell fate through the PLK1-FOXO3a-β-catenin signaling pathway by differentially regulating cuproptosis and EMT

铜通过PLK1-FOXO3a-β-catenin信号通路差异性地调控铜凋亡和上皮间质转化(EMT),从而调节细胞命运。

Lee, Hyo-Jun; Park, Ju-Hee; Kim, Do-Yeon; Kim, Dae-Young; Yi, Min-Jae; Choi, Wu-Seong; Na, Han-Heom; Chae, Sehyun; Oh, Young Taek; Kim, Keun-Cheol

Potent synthetic lethality between PLK1 and EYA family inhibitors in tumors of the central and peripheral nervous systems

PLK1 和 EYA 家族抑制剂在中枢和周围神经系统肿瘤中表现出强大的合成致死性

Nelson, Christopher B; Wells, Jadon K; Kesarwani, Ekaagra; Sobinoff, Alexander P; Fernando, Madushan; Gao, Jixuan; MacKenzie, Karen L; Poulos, Rebecca C; Nawaz, Urwah; Wang, Xiang; Ford, Heide L; Pickett, Hilda A

Bora bridges Aurora-A activation and substrate recognition of PLK1.

Bora 连接 Aurora-A 激活和 PLK1 的底物识别。

Miles Jennifer A, Batchelor Matthew, Walko Martin, Gunning Vanda, Wilson Andrew J, Wright Megan H, Bayliss Richard